- Reaction score
- 42
Here are the actual numbers from that Merck "dose-ranging" study I told you about earlier. That would be: "Clinical studies on the effects of oral finasteride, a type II 5a-reductase ibhibitor, on scalp hair in men with male pattern baldness", by K. D. Kaufman (Merck Research Labs, Rahway, NJ, USA). From the book "Hair Research for the Next Millenium", 1996. All the smaller doses were tested for only six months (M6), while the 5 mg dose was tested for 12 months (M12). I will list each dose separately, followed by its assessment period, followed by its haircount difference, followed by its change in serum DHT level:
placebo: M6, -7, -3.9%
0.01 mg: M6, -3, -10.8%
0.2 mg: M6, +61, -61.7%
1 mg: M6, +77, -68.7%
-----------------------
placebo: M12, -10, 0.0%
5 mg: M12, +95, -69.2%
placebo: M6, -7, -3.9%
0.01 mg: M6, -3, -10.8%
0.2 mg: M6, +61, -61.7%
1 mg: M6, +77, -68.7%
-----------------------
placebo: M12, -10, 0.0%
5 mg: M12, +95, -69.2%